Clinical Trials Browser

INDUSTRY × Interventional × Xerostomia × Clear all

NCT02446249 2025-09-25

Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction

Phase 1 Active not recruiting

Head and Neck Neoplasms, Xerostomia

NCT02990468 2023-03-15

BMX-HN

Phase 1/2 Completed

29 enrolled 14 charts

Head & NeckOther

Head and Neck Neoplasms, Xerostomia, Mucositis

NCT03601962 2020-01-27

Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer

Phase NA Terminated

Xerostomia

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Phase 3 Completed

188 enrolled 19 charts

Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

NCT02049112 2014-01-29

NIAGARA

Phase 4 Completed

Head and Neck Neoplasms, Sjogren's Syndrome, Xerostomia

NCT01316393 2011-11-09

Effects of Mucoprotective Product on Xerostomia

Phase 4 Completed

Xerostomia